These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 19642144)
21. C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells. Bram EE; Ifergan I; Grimberg M; Lemke K; Skladanowski A; Assaraf YG Biochem Pharmacol; 2007 Jun; 74(1):41-53. PubMed ID: 17481587 [TBL] [Abstract][Full Text] [Related]
22. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells. Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559 [TBL] [Abstract][Full Text] [Related]
24. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia. To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183 [TBL] [Abstract][Full Text] [Related]
25. Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporin A. Ejendal KF; Hrycyna CA Mol Pharmacol; 2005 Mar; 67(3):902-11. PubMed ID: 15598974 [TBL] [Abstract][Full Text] [Related]
26. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2. Sun R; Jiang B; Qi H; Zhang X; Yang J; Duan J; Li Y; Li G Cell Death Dis; 2015 Nov; 6(11):e1990. PubMed ID: 26583330 [TBL] [Abstract][Full Text] [Related]
27. Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer. To KK; Poon DC; Wei Y; Wang F; Lin G; Fu L Br J Pharmacol; 2015 Aug; 172(16):4089-106. PubMed ID: 25988710 [TBL] [Abstract][Full Text] [Related]
28. Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells. Priebsch A; Rompe F; Tönnies H; Kowalski P; Surowiak P; Stege A; Materna V; Lage H Oligonucleotides; 2006; 16(3):263-74. PubMed ID: 16978089 [TBL] [Abstract][Full Text] [Related]
29. Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding. Alqawi O; Bates S; Georges E Biochem J; 2004 Sep; 382(Pt 2):711-6. PubMed ID: 15139851 [TBL] [Abstract][Full Text] [Related]
30. Receptor for activated C-kinase 1 regulates the cell surface expression and function of ATP binding cassette G2. Ikebuchi Y; Ito K; Takada T; Anzai N; Kanai Y; Suzuki H Drug Metab Dispos; 2010 Dec; 38(12):2320-8. PubMed ID: 20858845 [TBL] [Abstract][Full Text] [Related]
31. Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway. Pick A; Wiese M ChemMedChem; 2012 Apr; 7(4):650-62. PubMed ID: 22354538 [TBL] [Abstract][Full Text] [Related]
32. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Imai Y; Ishikawa E; Asada S; Sugimoto Y Cancer Res; 2005 Jan; 65(2):596-604. PubMed ID: 15695404 [TBL] [Abstract][Full Text] [Related]
33. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2. Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120 [TBL] [Abstract][Full Text] [Related]
34. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
35. CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization. Zhou S; Liao L; Chen C; Zeng W; Liu S; Su J; Zhao S; Chen M; Kuang Y; Chen X; Li J Cancer Lett; 2013 Sep; 337(2):285-92. PubMed ID: 23623923 [TBL] [Abstract][Full Text] [Related]
36. Guanosine-induced decrease in side population of lung cancer cells: lack of correlation with ABCG2 expression. Su C; Picard P; Rathbone MP; Jiang S J Biol Regul Homeost Agents; 2010; 24(1):19-25. PubMed ID: 20385068 [TBL] [Abstract][Full Text] [Related]
37. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance. Liu L; Zuo LF; Guo JW Mol Med Rep; 2014 Apr; 9(4):1299-304. PubMed ID: 24535197 [TBL] [Abstract][Full Text] [Related]
38. Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2-Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors. Chang FW; Fan HC; Liu JM; Fan TP; Jing J; Yang CL; Hsu RJ Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098816 [TBL] [Abstract][Full Text] [Related]
39. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells. Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170 [TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]